EQS-News: Hydromer Reports Strategic Investment by JMEDTECH, and Formation of Its New Board of Directors

CONCORD NC - October 6, 2025 (NEWMEDIAWIRE) - Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, founded in 1980, is pleased to announce a strategic investment in its business, made by jMedtech. Alongside this partnership, Hydromer is strengthened by a refreshed Board of Directors. Michael Torti will continue to serve as CEO & Director, working with Chairman Jacqueline Zhang and the Board to provide strong leadership, deep industry expertise, and vision as Hydromer enters its next phase of growth and innovation. We extend our gratitude to Braeden Lichti and George Kovalyov for their leadership and contributions as they now depart the company. 

Hydromer and jMedtech are joining forces to build a future-oriented global medical device coating platform. This platform integrates UV-curable and thermal-cure coating systems, supported by advanced coating equipment and regionalized coating services, to provide customers worldwide with a comprehensive solution spanning R&D, validation, and mass production.

This move not only amplifies Hydromer’s technological and brand influence but also marks a critical milestone in jMedtech’s global expansion. By uniting with jMedtech, Hydromer connects capabilities across Asia and the Americas, establishing a mirror-delivery network covering major medical device markets. This significantly enhances supply chain resilience and responsiveness, creating greater value for customers.

“Our company couldn’t be more pleased to join forces with jMedtech and its fine leaders. For over 40 years, Hydromer has been an innovator in the surface conversion coatings industry and now, with the support of one of the most innovative companies in our industry, together we will bring perhaps the broadest range of coating capabilities, including automatic large-scale coating systems, to the Global Medical Device marketplace.  This is a great day for Hydromer, its shareholders, employees, and customers, and guarantees our future as a dominant player in the markets we serve,” said Michael Torti, CEO of Hydromer.

 About Hydromer

Hydromer, Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for a wide variety of applications. We are domiciled in Concord, NC. Our customers are located across the United States, Europe and Asia-Pacific. Our facilities are compliant to, Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. We manage numerous global B2B services such as the sale of proprietary coating formulations, custom coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and hold patents worldwide.

Contact:
Hydromer Inc.
Info@hydromer.com

Forward-Looking Statements

This press release contains forward-looking statements that are based on Hydromer’s current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

News Source: Hydromer, Inc